Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Dong Sheng Yue"'
Autor:
Qiang Zhang, Yu Zhang, Hui Chen, Lei-Na Sun, Bin Zhang, Dong-Sheng Yue, Chang-Li Wang, Zhen-Fa Zhang
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract The need for tumor postoperative treatments aimed at recurrence prevention and tissue regeneration have raised wide considerations in the context of the design and functionalization of implants. Herein, an injectable hydrogel system encapsul
Externí odkaz:
https://doaj.org/article/cf2bc6d2e7054c30ac91e480968474e9
Autor:
Yi‐Long Wu, Shun Lu, Ying Cheng, Qing Zhou, Hai‐Yan Tu, Qing‐Hua Zhou, Lv‐Hua Wang, Li Zhang, Jian‐Ying Zhou, Cheng Huang, Ming Chen, Cheng‐Ping Hu, Shao‐Kun Chuai, Xiao‐Nan Wang, Xiao‐Qing Liu, Ji‐Wei Liu, Peng‐Hui Zhou, Wei‐Zhi Chen, Ling‐Hua Yan, Yun‐Peng Liu, An‐Wen Liu, Xu‐Chao Zhang, Hui Li, Rong‐Rong Chen, Dong‐Mei Lin, Cong‐Ying Xie, Zheng‐Fei Zhu, Hui‐Ying Liang, Yong Song, Xiao‐Rong Dong, Ming‐Fang Zhao, Gui‐Bin Qiao, Jiu‐Wei Cui, Zi‐Ming Li, Zhi‐Jie Wang, Xiao‐Yuan Chen, Nong Yang, Gen Lin, Pan‐Wen Tian, Yun Fan, Qi‐Bin Song, Yuan Chen, Jian‐Chun Duan, Jia‐Lei Wang, Bo Zhu, Bu‐Hai Wang, Jun Zhao, Qi‐Tao Yu, Li‐Feng Wang, Hai‐Bo Zhang, Jie Hu, Rui Ma, Tong‐Mei Zhang, Jie Lin, Qian Chu, Sheng‐Xiang Ren, Yu Yao, Lin Wu, Hui‐Juan Wang, Fang Wu, Wen‐Zhao Zhong, Yi Hu, Ke‐Neng Chen, Jian Zhao, Fan Yang, Qun Wang, Dong‐Sheng Yue, Jian‐Ya Zhou, Peng Shen, Jia‐Tao Zhang, Xiao‐Long Yan, Mei‐Juan Huang, Wei‐Neng Feng, Li Li, Chinese Association of Lung Cancer, Guangdong Association of Clinical Trials (GACT)/Chinese Thoracic Oncology Group (CTONG)
Publikováno v:
Medicine Advances, Vol 1, Iss 4, Pp 293-305 (2023)
Abstract The importance of uncommon/rare oncogenic drivers in non‐small cell lung cancer (NSCLC) was underscored during the 20th China Lung Cancer Summit. These drivers, while present in a significant proportion of NSCLC patients, remain a challeng
Externí odkaz:
https://doaj.org/article/6cf86ef452334af4a74e37fd66750545
Autor:
Chao Zhang, Hua-Fei Chen, Shi Yan, Lin Wu, Li-Xu Yan, Xiao-Long Yan, Dong-Sheng Yue, Chun-Wei Xu, Min Zheng, Ji-Sheng Li, Si-Yang Liu, Ling-Ling Yang, Ben-Yuan Jiang, Qiu-Xiang Ou, Zhen-Bin Qiu, Yang Shao, Yi-Long Wu, Wen-Zhao Zhong
Publikováno v:
npj Precision Oncology, Vol 6, Iss 1, Pp 1-9 (2022)
Abstract Despite limited efficacy of immunotherapy for advanced non-small-cell lung cancer (NSCLC) with driver mutations, whether neoadjuvant immunotherapy could be clinically valuable in those patients warrants further investigation. We utilized 40
Externí odkaz:
https://doaj.org/article/b0266695bc4d46cb8301b21ed896e3fd
Autor:
Peng-Fei Tian, Yu-Chen Ma, Dong-Sheng Yue, Fan Liang, Chen-Guang Li, Chen Chen, Hua Zhang, Xiao-Yan Sun, Wu-Hao Huang, Zhen-Fa Zhang, Guang-Biao Zhou, Gui-Zhen Wang, Bin Zhang, Chang-Li Wang
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundEffective biomarkers for early diagnosis of lung cancer are needed. Previous studies have indicated positive associations between abnormal circulating cytokines and the etiology of lung cancer.MethodsBlood samples were obtained from 286 pat
Externí odkaz:
https://doaj.org/article/0184f8b7d0da4bb4aaa3ca2855dd7af3
Autor:
Wei‐Ran Liu, Bin Zhang, Chen Chen, Yue Li, Xin Ye, Dong‐Jiang Tang, Jun‐Cheng Zhang, Jing Ma, Yan‐Ling Zhou, Xian‐Jun Fan, Dong‐Sheng Yue, Chen‐Guang Li, Hua Zhang, Yu‐Chen Ma, Yan‐Song Huo, Zhen‐Fa Zhang, Shu‐Yu He, Chang‐Li Wang
Publikováno v:
Thoracic Cancer, Vol 11, Iss 11, Pp 3234-3242 (2020)
Background Circulating genetically abnormal cells (CACs) with specific chromosome variations have been confirmed to be present in non‐small cell lung cancer (NSCLC). However, the diagnostic performance of CAC detection remains unclear. This study a
Externí odkaz:
https://doaj.org/article/3de2d259d74f4698b0c5321befe24bc8
Autor:
Wenhua, Liang, Kaican, Cai, Qingdong, Cao, Chun, Chen, Haiquan, Chen, Jun, Chen, Ke-Neng, Chen, Qixun, Chen, Tianqing, Chu, Yuchao, Dong, Jiang, Fan, Wentao, Fang, Junke, Fu, Xiangning, Fu, Shugeng, Gao, Di, Ge, Guojun, Geng, Qing, Geng, Jie, He, Jian, Hu, Jie, Hu, Wei-Dong, Hu, Feng, Jiang, Tao, Jiang, Wenjie, Jiao, He-Cheng, Li, Qiang, Li, Shanqing, Li, Shuben, Li, Xiangnan, Li, Yong-De, Liao, Changhong, Liu, Hongxu, Liu, Yang, Liu, Zhuming, Lu, Qingquan, Luo, Haitao, Ma, Xiaojie, Pan, Guibin, Qiao, Shengxiang, Ren, Weiyu, Shen, Yong, Song, Daqiang, Sun, Guangsuo, Wang, Jie, Wang, Mengzhao, Wang, Qiwen, Wang, Wen-Xiang, Wang, Li, Wei, Ming, Wu, Nan, Wu, Hui, Xia, Shi-Dong, Xu, Fan, Yang, Kang, Yang, Yue, Yang, Fenglei, Yu, Zhen-Tao, Yu, Dong-Sheng, Yue, Lanjun, Zhang, Weidong, Zhang, Zhenfa, Zhang, Guofang, Zhao, Jian, Zhao, Xiaojing, Zhao, Chengzhi, Zhou, Qinghua, Zhou, Kunshou, Zhu, Yuming, Zhu, Toyoaki, Hida, Wolfram C M, Dempke, Antonio, Rossi, Marc, de Perrot, Robert A, Ramirez, Mariano, Provencio, Jay M, Lee, Antonio, Passaro, Lorenzo, Spaggiari, Jonathan, Spicer, Nicolas, Girard, Patrick M, Forde, Tony S K, Mok, Tina, Cascone, Jianxing, He
Publikováno v:
Translational lung cancer research. 11(9)
Autor:
Yue Li, Hai-lin Liu, Dong-sheng Yue, Chen Chen, Chen-guang Li, Zhen-fa Zhang, Sheng-qiang Xu, Hui-ping Lu, Tian-tian Gu, Chang-li Wang
Background In the tumor microenvironment, programmed death ligand 1(PD-L1) is a key protein upregulated by tumor cells in immune escape. Tumor-associated macrophages (TAMs) play a major role in this immunosuppression. Osteopontin (OPN) is related to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7fa856e68214589eba6c156209c70405
https://doi.org/10.21203/rs.3.rs-66234/v1
https://doi.org/10.21203/rs.3.rs-66234/v1
Autor:
Jun Ye Wang, Ling Juan Chen, Hao Long, Qi Wen Li, Wan Ming Hu, Nai Bin Chen, Li Zhang, Zhong Xing Liao, José López, Song Ran Liu, Qing Song Pang, Shuang Bing Xu, Steven H. Lin, Jing Ping Yun, Min Zhang Guo, Xin Wang, Hui Liu, Bo Qiu, Dong Sheng Yue, Wenhua Liang, Jin Yu Guo, Si Yu Wang, Tian Zhang, Yi Zhao
Publikováno v:
Journal of Cancer
Background: This study aimed to develop a predictive model based on the risk of locoregional recurrence (LRR) in epidermal growth factor receptor (EGFR)-mutant stage III-pN2 lung adenocarcinoma after complete resection. Methods: A total of 11,020 pat
The aim of the present study was to investigate the prognostic value of the combined platelet (PLT), fibrinogen (FBG), neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) (CO-NPF) for postoperative outcomes in patients with lu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76a73a298eb6067efcb23f45708dd47b
https://europepmc.org/articles/PMC5594242/
https://europepmc.org/articles/PMC5594242/
Publikováno v:
World Journal of Surgery. 36:455-462
The aim of this study was to investigate the relation between the metastatic lymph node ratio (LNR) and the prognosis of non-small-cell lung cancer (NSCLC).A total of 301 patients with N1 or N2 NSCLC who underwent complete pulmonary resection were an